GlassScriptPhysician profile
Amanda B Salter
NPI 1255644902
$3,552.65
in general payments reported to CMS, 2019-2025
23 companies · $1,132 in 2025
The $1,132 reported for 2025 was more than what 80% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62.23 · 2020: $238 · 2021: $149 · 2022: $493 · 2023: $599 · 2024: $879 · 2025: $1,132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,593 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,592.69 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $722.51 | 2022-2025 | Rocklatan, Clareon, Tryptyr |
| Tarsus Pharmaceuticals, INC. | $560.25 | 2024-2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $399.33 | 2021-2025 | Cequa, Xelpros |
| Bausch & Lomb Americas INC. | $364.16 | 2023-2025 | Miebo, Xiidra, Vyzulta |
| Sight Sciences, INC. | $287.63 | 2023-2025 | Omni Surgical System, Tearcare System, Sion Surgical Instrument |
| Galderma Laboratories, L.P. | $208.09 | 2019-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $136.69 | 2022-2024 | Tecnis Iol, Tecnis Simplicity, Veritas Vision System |
| Oyster Point Pharma, INC. | $133.00 | 2023-2025 | Tyrvaya, Ryzumvi |
| Biotissue Holdings INC. | $123.70 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $121.30 | 2025 | Eylea Hd |
| Novartis Pharmaceuticals Corporation | $100.99 | 2020-2022 | |
| Kala Pharmaceuticals, INC. | $99.14 | 2019-2021 | |
| Dompe US, INC. | $52.27 | 2021-2025 | Oxervate |
| Allergan, INC. | $48.18 | 2020-2022 | |
| Ocular Therapeutix, INC. | $32.05 | 2021-2025 | Dextenza |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| New World Medical,INC. | $28.65 | 2022-2023 | |
| Aerie Pharmaceuticals, INC. | $24.34 | 2021 | |
| Rxsight INC | $24.26 | 2024 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Light Adjustable Lens (Lal) |
| Rayner Intraocular Lenses Limited | $23.21 | 2023 | Rayone Aspheric, Rayone Emv, Omidria |
| Abbvie INC. | $19.91 | 2022 | |
| Harrow Eye, LLC | $16.34 | 2023 | Iheezo |
| Eyevance Pharmaceuticals LLC | $15.41 | 2022 | |
| Shire North American Group INC | $11.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Salter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.